🇺🇸 FDA
Patent

US 9717752

Uses of antagonists of hyaluronan signaling

granted A61KA61K31/702A61K31/715

Quick answer

US patent 9717752 (Uses of antagonists of hyaluronan signaling) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/702, A61K31/715, A61K31/726, A61K31/727